PharVision Advisers LLC bought a new position in Nova Ltd. (NASDAQ:NVMI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,703 shares of the semiconductor company's stock, valued at approximately $335,000.
Several other institutional investors have also recently made changes to their positions in NVMI. SG Americas Securities LLC lifted its holdings in shares of Nova by 352.8% in the 4th quarter. SG Americas Securities LLC now owns 3,618 shares of the semiconductor company's stock worth $713,000 after acquiring an additional 2,819 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its position in Nova by 1.0% in the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,169,625 shares of the semiconductor company's stock valued at $230,358,000 after acquiring an additional 11,915 shares during the last quarter. Blue Trust Inc. grew its position in Nova by 21.6% in the 4th quarter. Blue Trust Inc. now owns 1,462 shares of the semiconductor company's stock valued at $305,000 after acquiring an additional 260 shares during the last quarter. Swedbank AB bought a new position in Nova in the 4th quarter valued at $2,954,000. Finally, SkyOak Wealth LLC bought a new position in Nova in the 4th quarter valued at $327,000. Institutional investors own 82.99% of the company's stock.
Nova Trading Down 0.9%
Shares of Nova stock traded down $1.71 on Friday, hitting $183.00. 122,707 shares of the company traded hands, compared to its average volume of 229,928. The company has a market cap of $5.38 billion, a PE ratio of 31.88, a PEG ratio of 2.55 and a beta of 1.66. The stock's 50 day moving average price is $187.97 and its 200-day moving average price is $207.21. Nova Ltd. has a 52 week low of $154.00 and a 52 week high of $289.90.
Nova (NASDAQ:NVMI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The semiconductor company reported $2.18 EPS for the quarter, beating the consensus estimate of $2.08 by $0.10. Nova had a net margin of 27.33% and a return on equity of 22.33%. The business had revenue of $213.36 million during the quarter, compared to analyst estimates of $210.10 million. During the same quarter in the previous year, the business posted $1.39 EPS. The company's quarterly revenue was up 50.5% compared to the same quarter last year. As a group, research analysts anticipate that Nova Ltd. will post 7.52 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on NVMI shares. Benchmark cut their price objective on Nova from $295.00 to $280.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Citigroup cut their price objective on Nova from $290.00 to $280.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Cantor Fitzgerald decreased their price target on shares of Nova from $315.00 to $300.00 and set an "overweight" rating for the company in a research note on Friday, March 14th. Wall Street Zen raised shares of Nova from a "hold" rating to a "buy" rating in a research note on Thursday. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Nova in a research note on Friday, February 14th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Nova presently has a consensus rating of "Moderate Buy" and an average price target of $277.00.
Read Our Latest Report on NVMI
Nova Profile
(
Free Report)
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.
Read More

Before you consider Nova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nova wasn't on the list.
While Nova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.